Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SkinHealth Systems Inc.SKIN · Entity 6863 | Director · Chief Executive Officer | August 17, 2023 | August 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SkinHealth Systems Inc.
Report date August 17, 2023 · Filed August 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 702,933 |
Reported balance
After 2023-08-17 transaction · row 1
1 source rowRow 1 · 2023-08-17 · Purchase · Acquired 16,485 · Balance 702,933 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.0398 to $6.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.0398 to $6.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2023 Filed Aug 17, 2023 20:57 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | PurchaseClass A Common Stock | 16,485 | $6.05 | $99,815.03 |
DisclosureSEC source: 0001628280-23-029852 · wk-form4_1692305814.xml · nonDerivative · entry 1 Stanleick Andrew Roy · CIK 0001909193 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 702,933 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.0398 to $6.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 23:04 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 294,579 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-011061 · wf-form4_168082227335757.xml · nonDerivative · entry 1 Stanleick Andrew Roy · CIK 0001909193 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,448 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 5, 2023, in each case subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 5, 2023, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document |
| March 01, 2023 Filed Mar 7, 2023 01:46 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 58,536 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001818093-23-000011 · wf-form4_167815355586136.xml · nonDerivative · entry 1 Stanleick Andrew Roy · CIK 0001909193 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,869 F1 · kind: Represents a grant of restricted stock units that vests in one year on the anniversary of the grant date of March 1, 2023, subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vests in one year on the anniversary of the grant date of March 1, 2023, subject to continued service through the vesting date and certain acceleration rights. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 18:35 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 333,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001818093-22-000035 · wf-form4_164443169875872.xml · nonDerivative · entry 1 Stanleick Andrew Roy · CIK 0001909193 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 F1 · kind: Represents a grant of restricted stock units ("RSUs"); 12.5% of the RSUs will vest on the six-month anniversary of the Vesting Commencement Date of February 4, 2022, 12.5% of the RSUs will vest on the first anniversary of such Vesting Commencement Date, and 25% of the RSUs will vest on each of the second, third and fourth anniversaries of such Vesting Commencement Date, in each case subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units ("RSUs"); 12.5% of the RSUs will vest on the six-month anniversary of the Vesting Commencement Date of February 4, 2022, 12.5% of the RSUs will vest on the first anniversary of such Vesting Commencement Date, and 25% of the RSUs will vest on each of the second, third and fourth anniversaries of such Vesting Commencement Date, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.